- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nephros Inc (NEPH)
Assess today's live Nephros Inc (NEPH) share price, performance and insights using our live NASDAQ: NEPH stock exchange data.
Analyse the historical data and Nephros Inc share price performance charts on this page. Our technical summary section provides analysis on Nephros share price buy/sell indicators using real-time data (or discuss the Nephros (NEPH) stock price today with other investors in the Nephros NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ NEPH share price (ISIN: US6406714005) to enhance your trading decisions with our free investment tools and resources.
What Is the Nephros Inc Share Price Today?
The Nephros share price today is 4.660.
What Is the Stock Symbol for Nephros Inc
The stock symbol (or 'ticker') for Nephros Inc is "NEPH."
What Stock Exchange Does Nephros Inc Trade On?
Nephros Inc is listed and trades on the NASDAQ stock exchange.
Is Nephros Inc a Good Stock to Buy?
Determining whether Nephros Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Nephros Inc share price performance charts on this page. Our technical summary section provides analysis on Nephros share price buy/sell indicators using real-time data (or discuss the Nephros (NEPH) stock price today with other investors in the Nephros NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ NEPH share price (ISIN: US6406714005) to enhance your trading decisions with our free investment tools and resources.
What Is the Nephros Inc Share Price Today?
The Nephros share price today is 4.660.
What Is the Stock Symbol for Nephros Inc
The stock symbol (or 'ticker') for Nephros Inc is "NEPH."
What Stock Exchange Does Nephros Inc Trade On?
Nephros Inc is listed and trades on the NASDAQ stock exchange.
Is Nephros Inc a Good Stock to Buy?
Determining whether Nephros Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.650
4.950
52 wk Range
1.390
6.420
NEPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.6504.950
52 wk Range
1.3906.420
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NEPH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
7.000
Upside
+50.21%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Nephros Company Profile
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. It also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, bacteria, cysts, particulates, heavy metals, chemical compounds, scale build-up in downstream equipment, and other various contaminants. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Nephros Inc Earnings Call Summary for Q3/2025
- Nephros reported Q3 2025 EPS of $0.03 (vs. -$0.02 forecast) and revenue of $4.59M (vs. $3.8M expected), marking its fifth consecutive profitable quarter despite an 8.61% stock decline.
- Revenue increased 35% year-over-year to $4.8M with stable gross margins of 61%, while net income rose to $337,000 from $183,000 in Q3 2024.
- The company expanded beyond hospitals into municipalities and dialysis centers, launching a new PFAS removal solution as part of its market diversification strategy.
- Cash balance improved to $5.2M from $3.8M in December 2024, with management forecasting continued growth of $4.11M for Q4 2025 and $4.26M for Q1 2026.
- CEO Robert Banks expressed confidence in addressing market challenges, while the CFO emphasized maintaining profitability as the company balances expansion with financial discipline.
Last Updated: 06/11/2025, 22:38
Read Full TranscriptCompare NEPH to Peers and Sector
Metrics to compare | NEPH | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipNEPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 33.4x | 31.6x | 12.3x | |
PEG Ratio | 0.13 | 0.01 | 0.03 | |
Price/Book | 4.9x | 1.4x | 1.4x | |
Price / LTM Sales | 2.8x | 0.7x | 1.2x | |
Upside (Analyst Target) | 50.2% | 167.6% | 19.7% | |
Fair Value Upside | Unlock | 16.2% | 6.1% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.000
(+50.21% Upside)
Earnings
Latest Release
Nov 06, 2025
EPS / Forecast
0.03 / -0.02
Revenue / Forecast
4.59M / 3.80M
People Also Watch
FAQ
What Is the Nephros (NEPH) Share Price Today?
The live Nephros share price today is 4.660
What Stock Exchange Does Nephros (NEPH) Trade On?
Nephros is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Nephros?
The stock symbol (also called a 'ticker') for Nephros is "NEPH."
What Is the Current Nephros Market Cap?
As of today, Nephros market capitalisation is 49.52M.
What Is Nephros's (NEPH) Earnings Per Share (TTM)?
The Nephros EPS is currently 0.14 (Trailing Twelve Months).
When Is the Next Nephros Earnings Date?
Nephros's next earnings report will be released on 05 Mar 2026.
Is NEPH a Buy or Sell From a Technical Analyst Perspective?
Based on today's Nephros moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Nephros Stock Split?
Nephros has split 2 times. (See the NEPH stock split history page for full effective split date and price information.)
How Many Employees Does Nephros Have?
Nephros has 31 employees.
What is the current trading status of Nephros (NEPH)?
As of 24 Dec 2025, Nephros (NEPH) is trading at a price of 4.660, with a previous close of 4.850. The stock has fluctuated within a day range of 4.650 to 4.950, while its 52-week range spans from 1.390 to 6.420.
What Is Nephros (NEPH) Price Target According to Analysts?
The average 12-month price target for Nephros is USD7, with a high estimate of USD8 and a low estimate of USD6. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +50.21% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.